(Q57837650)
Statements
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma (English)
0 references
May 2012
0 references
48
0 references
7
0 references
1023-1030
0 references